ACCESS Newswire
31 Jan 2023, 15:13 GMT+10
LUND, SE / ACCESSWIRE / January 31, 2023 / BioInvent International (STO:BINV)
Lund, Sweden, January 31, 2023 - BioInvent International AB ('BioInvent') (Nasdaq Stockholm: BINV) today announced that the company's total number of shares as per January 31, 2023 amounts to 65,804,362 shares, corresponding to an equal number of votes.
The increase in the number of shares and votes results from the directed issue of USD 3 million (approximately SEK 31 million) to Leukemia & Lymphoma Society's Therapy Acceleration Program® (LLS TAP) by issuance of 836,478 shares, announced on January 17, 2023 in connection with BioInvent entered into a partnership with LLS TAP.
About BioInvent
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The Company's validated, proprietary F.I.R.S.T™ technology platform identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company's own clinical development pipeline and providing licensing and partnering opportunities. The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com. Follow us on Twitter: @BioInvent.
For further information, please contact:
Cecilia Hofvander
Senior Director Investor Relations
+46 (0)46 286 85 50
[email protected]
BioInvent International AB (publ)
Co. Reg. No.: 556537-7263
Visiting address: Ideongatan 1
Mailing address: 223 70 LUND
Phone: +46 (0)46 286 85 50
www.bioinvent.com
This information is information that BioInvent International is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2023-01-31 10:00 CET.
Attachments
Change in the number of shares and votes in BioInvent International AB
SOURCE: BioInvent International
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK, New York - U.S. stock markets closed in positive territory Monday despite the raging war in the Middle East which has killed...
NEW DELHI, India: Amid mounting U.S.-China trade tensions, Apple has sharply increased iPhone shipments from India to the United States,...
WASHINGTON, D.C.: The U.S. government estimates that Huawei will only be able to manufacture up to 200,000 advanced AI chips next year—well...
SAN FRANCISCO, California: After months of muted IPO activity in the fintech world, digital bank Chime Financial reignited investor...
TOKYO, Japan: Nintendo's latest console is off to a roaring start. The company says it has sold over 3.5 million units of the newly...
LONDON, UK: Crude prices surged this week as investors welcomed fresh signs of progress in U.S.-China relations, lifting hopes of reduced...
Ohio, [US], June 15 (ANI): Researchers are working to improve the way we use evolutionary modeling to understand drug resistance. The...
Washington [US], June 15 (ANI): 'The Boys' star Erin Moriarty has taken to social media to share her recent diagnosis with Graves'...
Cultural exchanges between the two countries not only greatly enrich diverse cultural experiences for Chinese and American people,...
(250613) -- NEW YORK, June 13, 2025 (Xinhua) -- Young musicians perform at an event titled Youth Dialogue for the Future in New York...
Washington [US], June 12 (ANI): Renowned director Robert Eggers is set to bring Charles Dickens' timeless classic 'A Christmas Carol'...
ABU DHABI, 9th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery...